Long COVID and Its Management

Overview

Journal Int J Biol Sci

Specialty Biology

Date 2022 Jul 25

PMID 35874958

Authors

Ho Cheng Koc

Jing Xiao

Weiwei Liu

Yong Li

Guokai Chen

Affiliations

Soon will be listed here.

Abstract

The pandemic of COVID-19 is the biggest public health crisis in 21 Century. Besides the acute symptoms after infection, patients and society are also being challenged by the long-term health complications associated with COVID-19, commonly known as long COVID. While health professionals work hard to find proper treatments, large amount of knowledge has been accumulated in recent years. In order to deal with long COVID efficiently, it is important for people to keep up with current progresses and take proactive actions on long COVID. For this purpose, this review will first introduce the general background of long COVID, and then discuss its risk factors, diagnostic indicators and management strategies. This review will serve as a useful resource for people to understand and prepare for long COVID that will be with us in the foreseeable future.

Citing Articles

Spatial transcriptomics of the epipharynx in long COVID identifies SARS-CoV-2 signalling pathways and the therapeutic potential of epipharyngeal abrasive therapy.

Nishi K, Yoshimoto S, Tanaka T, Kimura S, Tsunoda T, Watanabe A Sci Rep. 2025; 15(1):8618.

PMID: 40074801 PMC: 11903674. DOI: 10.1038/s41598-025-92908-7.

COVID-19 infection and longevity: an observational and mendelian randomization study.

Qiu S, Liu J, Guo J, Zhang Z, Guo Y, Hu Y J Transl Med. 2025; 23(1):283.

PMID: 40050903 PMC: 11887240. DOI: 10.1186/s12967-024-05932-y.

Long COVID and Lung Involvement: A One-Year Longitudinal, Real-Life Study.

Stefania M, Toma C, Bondor C, Maria R, Florin P, Adina M Medicina (Kaunas). 2025; 61(2).

PMID: 40005421 PMC: 11857727. DOI: 10.3390/medicina61020304.

Predictors for Anxiety and Stress in Long COVID: A Study in the Brazilian Population.

de Macedo Rocha D, Pedroso A, Sousa L, Gir E, Reis R Int J Environ Res Public Health. 2025; 22(2).

PMID: 40003484 PMC: 11855483. DOI: 10.3390/ijerph22020258.

Virtual recovery: efficacy of telerehabilitation on dyspnea, pain, and functional capacity in post-COVID-19 syndrome.

Yasaci Z, Mustafaoglu R, Ozgur O, Kuveloglu B, Esen Y, Ozmen O Ir J Med Sci. 2025; .

PMID: 39920519 DOI: 10.1007/s11845-025-03899-3.

References

Hagenlocher Y, Lorentz A . Immunomodulation of mast cells by nutrients. Mol Immunol. 2014; 63(1):25-31. DOI: 10.1016/j.molimm.2013.12.005. View

Lai C, Shih T, Ko W, Tang H, Hsueh P . Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020; 55(3):105924. PMC: 7127800. DOI: 10.1016/j.ijantimicag.2020.105924. View

Xie Y, Xu E, Bowe B, Al-Aly Z . Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022; 28(3):583-590. PMC: 8938267. DOI: 10.1038/s41591-022-01689-3. View

Davis H, Assaf G, McCorkell L, Wei H, Low R, Reem Y . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021; 38:101019. PMC: 8280690. DOI: 10.1016/j.eclinm.2021.101019. View

Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

Fu W, Ho P, Liu C, Tzeng K, Nayeem N, Moore J . Reconcile the debate over protective effects of BCG vaccine against COVID-19. Sci Rep. 2021; 11(1):8356. PMC: 8052320. DOI: 10.1038/s41598-021-87731-9. View

Sugiyama A, Miwata K, Kitahara Y, Okimoto M, Abe K, E B . Long COVID occurrence in COVID-19 survivors. Sci Rep. 2022; 12(1):6039. PMC: 8996498. DOI: 10.1038/s41598-022-10051-z. View

Sun B, Tang N, Peluso M, Iyer N, Torres L, Donatelli J . Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations. Cells. 2021; 10(2). PMC: 7918597. DOI: 10.3390/cells10020386. View

Wiersinga W, Rhodes A, Cheng A, Peacock S, Prescott H . Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020; 324(8):782-793. DOI: 10.1001/jama.2020.12839. View

10.

Lu Z, Zhou H, Wu W, Fu T, Yan M, He Z . Alterations in the Composition of Intestinal DNA Virome in Patients With COVID-19. Front Cell Infect Microbiol. 2021; 11:790422. PMC: 8653907. DOI: 10.3389/fcimb.2021.790422. View

11.

Upton C, Van Wijk R, Mockeliunas L, Simonsson U, McHarry K, van den Hoogen G . Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double-blind, randomised, controlled, phase 3 trial. EClinicalMedicine. 2022; 48:101414. PMC: 9098089. DOI: 10.1016/j.eclinm.2022.101414. View

12.

Junqueira-Kipnis A, Dos Anjos L, Barbosa L, da Costa A, Borges K, Cardoso A . BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020; 21(1):881. PMC: 7586662. DOI: 10.1186/s13063-020-04822-0. View

13.

Glynne P, Tahmasebi N, Gant V, Gupta R . Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines. J Investig Med. 2021; 70(1):61-67. PMC: 8494538. DOI: 10.1136/jim-2021-002051. View

14.

Pinto M, Lambert N, Downs C, Abrahim H, Hughes T, Rahmani A . Antihistamines for Postacute Sequelae of SARS-CoV-2 Infection. J Nurse Pract. 2022; 18(3):335-338. PMC: 8820139. DOI: 10.1016/j.nurpra.2021.12.016. View

15.

Fricke L, Glockner S, Dreier M, Lange B . Impact of non-pharmaceutical interventions targeted at COVID-19 pandemic on influenza burden - a systematic review. J Infect. 2020; 82(1):1-35. PMC: 9183207. DOI: 10.1016/j.jinf.2020.11.039. View

16.

Rossato M, Brilli E, Ferri N, Giordano G, Tarantino G . Observational study on the benefit of a nutritional supplement, supporting immune function and energy metabolism, on chronic fatigue associated with the SARS-CoV-2 post-infection progress. Clin Nutr ESPEN. 2021; 46:510-518. PMC: 8420132. DOI: 10.1016/j.clnesp.2021.08.031. View

17.

Taquet M, Geddes J, Husain M, Luciano S, Harrison P . 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021; 8(5):416-427. PMC: 8023694. DOI: 10.1016/S2215-0366(21)00084-5. View

18.

Townsend L, Dyer A, Jones K, Dunne J, Mooney A, Gaffney F . Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020; 15(11):e0240784. PMC: 7652254. DOI: 10.1371/journal.pone.0240784. View

19.

Sudre C, Murray B, Varsavsky T, Graham M, Penfold R, Bowyer R . Attributes and predictors of long COVID. Nat Med. 2021; 27(4):626-631. PMC: 7611399. DOI: 10.1038/s41591-021-01292-y. View

20.

Halpin S, McIvor C, Whyatt G, Adams A, Harvey O, McLean L . Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2020; 93(2):1013-1022. DOI: 10.1002/jmv.26368. View